{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T21:49:35Z","timestamp":1777585775805,"version":"3.51.4"},"reference-count":90,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,28]],"date-time":"2024-07-28T00:00:00Z","timestamp":1722124800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDB\/00481\/2020"],"award-info":[{"award-number":["UIDB\/00481\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDP\/00481\/2020"],"award-info":[{"award-number":["UIDP\/00481\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDB\/04106\/2020"],"award-info":[{"award-number":["UIDB\/04106\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["2023.01947"],"award-info":[{"award-number":["2023.01947"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["331151"],"award-info":[{"award-number":["331151"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.compbiomed.2024.108961","type":"journal-article","created":{"date-parts":[[2024,8,4]],"date-time":"2024-08-04T23:44:19Z","timestamp":1722815059000},"page":"108961","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Next-generation chemotherapy treatments based on black hole algorithms: From cancer remission to chronic disease management"],"prefix":"10.1016","volume":"180","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4299-1263","authenticated-orcid":false,"given":"Marco P.","family":"Soares dos Santos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0020-2265","authenticated-orcid":false,"given":"Rodrigo M.C.","family":"Bernardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6820-2483","authenticated-orcid":false,"given":"Jo\u00e3oV.","family":"Vidal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8641-2505","authenticated-orcid":false,"given":"Delfim F.M.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos A.R.","family":"Herdeiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00e9lder A.","family":"Santos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gil","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.compbiomed.2024.108961_bib1","article-title":"A comparative study between conventional chemotherapy and photothermal activated nano-sized targeted drug delivery to solid tumor","volume":"166","author":"Shahvandi","year":"2023","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.compbiomed.2024.108961_bib2","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.compbiomed.2024.108961_bib3","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1002\/ijc.33588","article-title":"Cancer statistics for the year 2020: an overview","volume":"149","author":"Ferlay","year":"2021","journal-title":"Int. J. Cancer"},{"issue":"3","key":"10.1016\/j.compbiomed.2024.108961_bib4","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1001\/jamaoncol.2021.6987","article-title":"Cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life years for 29 cancer groups from 2010 to 2019. A systematic analysis for the global burden of disease study 2019","volume":"8","year":"2022","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.compbiomed.2024.108961_bib5","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/j.ejca.2021.07.039","article-title":"The European cancer burden in 2020: incidence and mortality estimates for 40 countries and 25 major cancers","volume":"157","author":"Dyba","year":"2021","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.compbiomed.2024.108961_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/10732748221095955","article-title":"Cancer incidence and mortality in asian countries: a trend analysis","volume":"29","author":"Huang","year":"2022","journal-title":"Cancer Control"},{"key":"10.1016\/j.compbiomed.2024.108961_bib7","first-page":"17","article-title":"Cancer statistics","volume":"73","author":"Siegel","year":"2023","journal-title":"CA A Cancer J. Clin."},{"key":"10.1016\/j.compbiomed.2024.108961_bib8","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00262-021-03013-3","article-title":"Chemotherapy: a double-edged sword in cancer treatment","volume":"71","author":"Behranvand","year":"2022","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.compbiomed.2024.108961_bib9","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/s44222-023-00087-9","article-title":"Measuring and modelling tumour heterogeneity across scales","volume":"1","author":"Beeghly","year":"2023","journal-title":"Nat. Rev. Bioeng."},{"key":"10.1016\/j.compbiomed.2024.108961_bib10","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1038\/s41588-020-0630-5","article-title":"Unraveling tumor\u2013immune heterogeneity in advanced ovarian cancer uncovers immunogenic effect of chemotherapy","volume":"52","author":"Jim\u00e9nez-S\u00e1nchez","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1016\/j.compbiomed.2024.108961_bib11","first-page":"580","article-title":"Delineating the evolutionary dynamics of cancer from theory to reality","volume":"1","author":"Bozic","year":"2020","journal-title":"Nat. Can. (Ott.)"},{"issue":"2","key":"10.1016\/j.compbiomed.2024.108961_bib12","article-title":"Classical mathematical models for prediction of response to chemotherapy and immunotherapy","volume":"18","author":"Laleh","year":"2022","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.compbiomed.2024.108961_bib13","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","article-title":"A view on drug resistance in cancer","volume":"575","author":"Vasan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.compbiomed.2024.108961_bib14","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41571-020-0359-1","article-title":"Progress in refining the clinical management of cancer of unknown primary in the molecular era","volume":"17","author":"Rassy","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"3\u20134","key":"10.1016\/j.compbiomed.2024.108961_bib15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.drudis.2012.07.015","article-title":"Low-dose metronomic chemotherapy: from past experience to new paradigms in the treatment of cancer","volume":"18","author":"Loven","year":"2013","journal-title":"Drug Discov. Today"},{"key":"10.1016\/j.compbiomed.2024.108961_bib16","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nrclinonc.2016.64","article-title":"Pharmacokinetics of metronomic chemotherapy: a neglected but crucial aspect","volume":"13","author":"Bocci","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"14","key":"10.1016\/j.compbiomed.2024.108961_bib17","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.1158\/1078-0432.CCR-16-3083","article-title":"Clinically relevant concentrations of anticancer drugs: a guide for nonclinical studies","volume":"23","author":"Liston","year":"2017","journal-title":"Clin. Cancer Res."},{"issue":"9","key":"10.1016\/j.compbiomed.2024.108961_bib18","doi-asserted-by":"crossref","first-page":"e1609","DOI":"10.1002\/onco.13822","article-title":"Relative dose intensity of chemotherapy and survival in patients with advanced stage solid tumor cancer: a systematic review and meta-analysis","volume":"26","author":"Nielson","year":"2021","journal-title":"Oncol."},{"key":"10.1016\/j.compbiomed.2024.108961_bib19","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/s41585-020-0335-7","article-title":"Intermittent versus continuous androgen deprivation therapy for advanced prostate cancer","volume":"17","author":"Perera","year":"2020","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.compbiomed.2024.108961_bib20","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/S1470-2045(18)30094-9","article-title":"Chemotherapy medication errors","volume":"19","author":"Weingart","year":"2018","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.compbiomed.2024.108961_bib21","doi-asserted-by":"crossref","first-page":"e200","DOI":"10.1016\/S1470-2045(19)30145-7","article-title":"Dose recommendations for anticancer drugs in patients with renal or hepatic impairment","volume":"20","author":"Krens","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.compbiomed.2024.108961_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2017.06.020","article-title":"Trial designs and results supporting treatment de-escalation and escalation","volume":"34","author":"Regan","year":"2017","journal-title":"Breast"},{"key":"10.1016\/j.compbiomed.2024.108961_bib23","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/S0140-6736(20)30974-0","article-title":"Pancreatic cancer","volume":"395","author":"Mizrahi","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.compbiomed.2024.108961_bib24","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(18)32552-2","article-title":"Epithelial ovarian cancer","volume":"393","author":"Lheureux","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.compbiomed.2024.108961_bib25","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1016\/S0140-6736(21)01550-6","article-title":"Head and neck cancer","volume":"398","author":"Mody","year":"2021","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.compbiomed.2024.108961_bib26","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ccell.2015.10.012","article-title":"Immunological effects of conventional chemotherapy and targeted anticancer agents","volume":"28","author":"Galluzzi","year":"2015","journal-title":"Cancer Cell"},{"key":"10.1016\/j.compbiomed.2024.108961_bib27","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/s41571-019-0299-9","article-title":"Towards personalized treatment for early stage HER2-positive breast cancer","volume":"17","author":"Goutsouliak","year":"2020","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"6481","key":"10.1016\/j.compbiomed.2024.108961_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/science.aba7365","article-title":"CRISPR-engineered T cells in patients withrefractory cancer","volume":"367","author":"Stadtmauer","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.compbiomed.2024.108961_bib29","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.compbiomed.2014.11.002","article-title":"Adaptive robust control of cancer chemotherapy in the presence of parametric uncertainties: a comparison between three hypotheses","volume":"56","author":"Moradi","year":"2015","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.compbiomed.2024.108961_bib30","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.bspc.2018.09.016","article-title":"Cancer therapy optimization based on multiple model adaptive control","volume":"48","author":"Teles","year":"2019","journal-title":"Biomed Signal Proces."},{"key":"10.1016\/j.compbiomed.2024.108961_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.bspc.2020.101861","article-title":"Optimal adaptive intuitionistic fuzzy logic control of anti-cancer drugdelivery systems","volume":"58","author":"Karar","year":"2020","journal-title":"Biomed Signal Proces"},{"key":"10.1016\/j.compbiomed.2024.108961_bib32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.mbs.2009.08.004","article-title":"On optimal delivery of combination therapy for tumors","volume":"222","author":"d'Onofrio","year":"2009","journal-title":"Math. Biosci."},{"issue":"11","key":"10.1016\/j.compbiomed.2024.108961_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e31771","article-title":"Universe-inspired algorithms for control engineering: a Review","volume":"10","author":"Bernardo","year":"2024","journal-title":"Heliyon"},{"issue":"43","key":"10.1016\/j.compbiomed.2024.108961_bib34","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2310223120","article-title":"On the roles of function and selection in evolving systems","volume":"120","author":"Wong","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.compbiomed.2024.108961_bib35","series-title":"Cambridge Monographs on Mathematical Physics. Ch. 9","author":"Hawking","year":"2011"},{"key":"10.1016\/j.compbiomed.2024.108961_bib36","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/s41568-023-00568-4","article-title":"Dissecting metastasis using preclinical models and methods","volume":"23","author":"Hebert","year":"2023","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.compbiomed.2024.108961_bib37","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.molonc.2008.04.001","article-title":"Imaging and cancer: a review","volume":"2","author":"Fass","year":"2008","journal-title":"Mol. Oncol."},{"issue":"37","key":"10.1016\/j.compbiomed.2024.108961_bib38","doi-asserted-by":"crossref","first-page":"e4874","DOI":"10.1097\/MD.0000000000004874","article-title":"Tumor growth rate of invasive breast cancers during wait times for surgery assessed by ultrasonography","volume":"95","author":"Lee","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.compbiomed.2024.108961_bib39","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.jconrel.2020.08.012","article-title":"Controlled anti-cancer drug release through advanced nano-drug delivery systems: static and dynamic targeting strategies","volume":"327","author":"Kashkooli","year":"2020","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.compbiomed.2024.108961_bib40","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.addr.2018.07.002","article-title":"Drug delivery systems for programmed and on-demand release","volume":"132","author":"Davoodi","year":"2018","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.compbiomed.2024.108961_bib41","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adh5325","article-title":"Conformable ultrasound breast patch for deep tissue scanning and imaging","volume":"9","author":"Du","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.compbiomed.2024.108961_bib42","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s41467-023-44634-9","article-title":"From lab to life: how wearable devices can improve health equity","volume":"15","author":"Walter","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.compbiomed.2024.108961_bib43","first-page":"1","article-title":"Closed-loop automated drug infusion regulator: a clinically translatable, closed-loop drug delivery system for personalized drug dosing","volume":"5","author":"DeRidder","year":"2024","journal-title":"M\u00e9d."},{"key":"10.1016\/j.compbiomed.2024.108961_bib44","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s43856-021-00020-4","article-title":"Improving personalized tumor growth predictions using a Bayesian combination of mechanistic modeling and machine learning","volume":"1","author":"Mascheroni","year":"2021","journal-title":"Commun. Med."},{"key":"10.1016\/j.compbiomed.2024.108961_bib45","author":"Ansoldi"},{"key":"10.1016\/j.compbiomed.2024.108961_bib46","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0022-5193(03)00221-2","article-title":"Does tumor growth follow a \u201cuniversal law\u201d","volume":"225","author":"Guiot","year":"2003","journal-title":"J. Theor. Biol."},{"key":"10.1016\/j.compbiomed.2024.108961_bib47","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.cell.2015.11.002","article-title":"Improving cancer treatment via mathematical modeling: surmounting the challenges is worth the effort","volume":"163","author":"Michor","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.compbiomed.2024.108961_bib48","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/nrclinonc.2015.204","article-title":"Computational oncology - mathematical modelling of drug regimens for precision medicine","volume":"13","author":"Barbolosi","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.compbiomed.2024.108961_bib49","first-page":"4770","article-title":"Tumor development under angiogenic signaling: a dynamical theory of tumor growth, treatment response, and post-vascular dormancy","volume":"59","author":"Hahnfeldt","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.compbiomed.2024.108961_bib50","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1137\/21M1395326","article-title":"The structure of optimal protocols for a mathematical model of chemotherapy with antiangiogenic effects","volume":"60","author":"Ledzewicz","year":"2022","journal-title":"SIAM J. Control Optim."},{"key":"10.1016\/j.compbiomed.2024.108961_bib51","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.physa.2016.07.076","article-title":"Understanding the antiangiogenic effect of metronomic chemotherapy through a simple mathematical model","volume":"464","author":"Rodrigues","year":"2016","journal-title":"Physica A"},{"key":"10.1016\/j.compbiomed.2024.108961_bib52","doi-asserted-by":"crossref","DOI":"10.1158\/1078-0432.CCR-06-2362","article-title":"A physiologically based pharmacokinetic model of docetaxel disposition: from mouse to man","volume":"13","author":"Bradshaw-Pierce","year":"2007","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.compbiomed.2024.108961_bib53","first-page":"5","volume":"Ch. 1","author":"Sch\u00e4ttler","year":"2015"},{"key":"10.1016\/j.compbiomed.2024.108961_bib54","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.compbiomed.2024.108961_bib55","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.mbs.2004.06.003","article-title":"Tumour eradication by antiangiogenic therapy: analysis and extensions of the model by Hahnfeldt et al. (1999)","volume":"191","author":"d'Onofrio","year":"2004","journal-title":"Math. Biosci."},{"key":"10.1016\/j.compbiomed.2024.108961_bib56","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nrclinonc.2009.146","article-title":"Cyclophosphamide and cancer: golden anniversary","volume":"6","author":"Emadi","year":"2009","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.compbiomed.2024.108961_bib57","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41523-020-0171-1","article-title":"Immunostimulatory and anti-tumor metronomic cyclophosphamide regimens assessed in primary orthotopic and metastatic murine breast cancer","volume":"6","author":"Khan","year":"2020","journal-title":"npj Breast Cancer"},{"key":"10.1016\/j.compbiomed.2024.108961_bib58","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ctrv.2015.11.005","article-title":"Low dose cyclophosphamide: mechanisms of T cell modulation","volume":"42","author":"Madondo","year":"2016","journal-title":"Cancer Treat Rev."},{"key":"10.1016\/j.compbiomed.2024.108961_bib59","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/S1470-2045(19)30617-5","article-title":"Vinorelbine and continuous low-dose cyclophosphamide as maintenance chemotherapy in patients with high-risk rhabdomyosarcoma (RMS 2005): a multicentre, open-label, randomised, phase 3 trial","volume":"20","author":"Bisogno","year":"2019","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.compbiomed.2024.108961_bib60","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/S0140-6736(16)32455-2","article-title":"Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial","volume":"389","author":"Balar","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/j.compbiomed.2024.108961_bib61","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1007\/s00280-019-03954-8","article-title":"Alternative dosing regimens for atezolizumab: an example of model-informed drug development in the postmarketing setting","volume":"84","author":"Morrissey","year":"2019","journal-title":"Cancer Chemother. Pharmacol."},{"key":"10.1016\/j.compbiomed.2024.108961_bib62","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.fss.2013.09.004","article-title":"Approximations by LR-type fuzzy numbers","volume":"257","author":"Yeh","year":"2014","journal-title":"Fuzzy Set Syst."},{"key":"10.1016\/j.compbiomed.2024.108961_bib63","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1038\/s41591-022-01746-x","article-title":"The future of early cancer detection","volume":"28","author":"Fitzgerald","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.compbiomed.2024.108961_bib64","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1056\/NEJMoa1600249","article-title":"Breast-cancer tumor size, overdiagnosis, and mammography screening effectiveness","volume":"375","author":"Welch","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.compbiomed.2024.108961_bib65","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/nrclinonc.2010.39","article-title":"Tumor size and survival in breast cancer \u2014 a reappraisal","volume":"7","author":"Foulkes","year":"2010","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.compbiomed.2024.108961_bib66","series-title":"Mathematical Models of Cancer and Different Therapies, Ch. 10","author":"Padmanabhan","year":"2021"},{"key":"10.1016\/j.compbiomed.2024.108961_bib67","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1146\/annurev-bioeng-071910-124729","article-title":"Multiscale cancer modeling","volume":"13","author":"Deisboeck","year":"2011","journal-title":"Annu. Rev. Biomed. Eng."},{"key":"10.1016\/j.compbiomed.2024.108961_bib68","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2017.0703","article-title":"Towards personalized computational oncology: from spatial models of tumour spheroids, to organoids, to tissues","volume":"15","author":"Karolak","year":"2018","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.compbiomed.2024.108961_bib69","first-page":"1","article-title":"Monitoring tumor growth rate to predict immune checkpoint inhibitors' treatment outcome in advanced NSCLC","volume":"14","author":"Dall'Olio","year":"2022","journal-title":"Ther. Adv. Med. Oncol."},{"key":"10.1016\/j.compbiomed.2024.108961_bib70","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1038\/s41591-021-01558-5","article-title":"Digital twins for predictive oncology will be a paradigm shift for precision cancer care","volume":"27","author":"Hernandez-Boussard","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.compbiomed.2024.108961_bib71","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1038\/s41419-022-05437-w","article-title":"High-confidence cancer patient stratification through multiomics investigation of DNA repair disorders","volume":"13","author":"Mkrtchyan","year":"2022","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.compbiomed.2024.108961_bib72","first-page":"114","article-title":"A comprehensive review of artificial intelligence approaches in omics data processing: evaluating progress and challenges","volume":"2","author":"Ali","year":"2023","journal-title":"International Journal of Mathematics, Statistics, and Computer Science"},{"key":"10.1016\/j.compbiomed.2024.108961_bib73","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1038\/s41587-022-01379-y","article-title":"A multiplex implantable microdevice assay identifies synergistic combinations of cancer immunotherapies and conventional drugs","volume":"40","author":"Tatarova","year":"2022","journal-title":"Nat. Biotechnol."},{"issue":"122","key":"10.1016\/j.compbiomed.2024.108961_bib74","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3003276","article-title":"First-in-Human testing of a wirelessly controlled drug delivery microchip","volume":"4","author":"Farra","year":"2012","journal-title":"Sci. Transl. Med."},{"issue":"5","key":"10.1016\/j.compbiomed.2024.108961_bib75","doi-asserted-by":"crossref","first-page":"e1143","DOI":"10.1097\/SLA.0000000000005385","article-title":"First-in-Human intrathoracic implantation of multidrug-eluting microdevices for in situ chemotherapeutic sensitivity testing as proof of concept in nonsmall cell lung cancer","volume":"277","author":"Tsai","year":"2023","journal-title":"Ann. Surg."},{"key":"10.1016\/j.compbiomed.2024.108961_bib76","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s43856-022-00199-0","article-title":"Artificial intelligence and machine learning in cancer imaging","volume":"2","author":"Koh","year":"2022","journal-title":"Commun. Med."},{"issue":"1","key":"10.1016\/j.compbiomed.2024.108961_bib77","first-page":"167","article-title":"Breast cancer images classification using a new transfer learning technique","volume":"4","author":"Mukhlif","year":"2023","journal-title":"Iraqi Journal for Computer Science and Mathematics"},{"issue":"1","key":"10.1016\/j.compbiomed.2024.108961_bib78","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.mayocp.2014.10.003","article-title":"Clinical applications of biomedical microdevices for controlled drug delivery","volume":"90","author":"Gurman","year":"2015","journal-title":"Mayo Clin. Proc."},{"issue":"6596","key":"10.1016\/j.compbiomed.2024.108961_bib79","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1126\/science.abm1703","article-title":"A transient, closed-loop network of wireless, body-integrated devices for autonomous electrotherapy","volume":"376","author":"Choi","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.compbiomed.2024.108961_bib80","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1038\/s12276-023-01114-w","article-title":"Normalization of the tumor microenvironment by harnessing vascular and immune modulation to achieve enhanced cancer therapy","volume":"55","author":"Choi","year":"2023","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.compbiomed.2024.108961_bib81","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jconrel.2024.01.065","article-title":"A multivalent CD44 glycoconjugate vaccine candidate for cancer immunotherapy","volume":"367","author":"Freitas","year":"2024","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.compbiomed.2024.108961_bib82","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/s41392-023-01332-8","article-title":"Hypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions","volume":"8","author":"Chen","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.compbiomed.2024.108961_bib83","article-title":"Stochastic modeling of phenotypic switching and chemoresistance in cancer cell populations","volume":"9","author":"Kumar","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiomed.2024.108961_bib84","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202300692","article-title":"Cancer models on chip: paving the way to large-scale trial applications","volume":"35","author":"Gil","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.compbiomed.2024.108961_bib85","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2305322120","article-title":"Immune-infiltrated kidney organoid-on-chip model for assessing T cell bispecific antibodies","volume":"120","author":"Kroll","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.compbiomed.2024.108961_bib86","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/s41586-022-04437-2","article-title":"Effective drug combinations in breast, colon and pancreatic cancer cells","volume":"603","author":"Jaaks","year":"2022","journal-title":"Nature"},{"key":"10.1016\/j.compbiomed.2024.108961_bib87","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1137\/S1052623496303470","article-title":"Convergence properties of the Nelder-Mead simplex method in low dimensions","volume":"9","author":"Lagarias","year":"1998","journal-title":"SIAM J. Optim."},{"key":"10.1016\/j.compbiomed.2024.108961_bib88","doi-asserted-by":"crossref","DOI":"10.1038\/srep18579","article-title":"Magnetic levitation-based electromagnetic energy harvesting: a semi-analytical non-linear model for energy transduction","volume":"6","author":"Soares dos Santos","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiomed.2024.108961_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2023.106542","article-title":"Capacitive stimulation-sensing system for instrumented bone implants: finite element model to predict the electric stimuli delivered to the interface","volume":"154","author":"Ramos","year":"2023","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.compbiomed.2024.108961_bib90","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.1038\/s41598-021-82589-3","article-title":"Towards an effective sensing technology to monitor micro-scale interface loosening of bioelectronic implants","volume":"11","author":"Soares dos Santos","year":"2021","journal-title":"Sci. Rep."}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482524010461?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482524010461?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T20:01:59Z","timestamp":1777406519000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010482524010461"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":90,"alternative-id":["S0010482524010461"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2024.108961","relation":{},"ISSN":["0010-4825"],"issn-type":[{"value":"0010-4825","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Next-generation chemotherapy treatments based on black hole algorithms: From cancer remission to chronic disease management","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2024.108961","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"108961"}}